Nix Inhibitors
Nix inhibitors represent a diverse class of chemicals with distinct mechanisms of action on the intricate signaling pathways governing Nix expression and function. Mitochondrial division inhibitors, Mitochondrial division inhibitor 1 and Mdivi-1, directly target mitochondrial fission and hinder Nix translocation to mitochondria, providing specific tools for studying Nix-related cellular processes. Spautin-1, an autophagy inhibitor, indirectly influences Nix by targeting the autophagic pathway. By inhibiting USP10 and USP13, Spautin-1 enhances autophagy, leading to the degradation of Nix. CCCP, a mitochondrial uncoupler, indirectly inhibits Nix by disrupting mitochondrial membrane potential, providing an indirect mechanism for inhibiting Nix-mediated processes by disrupting the intricate network of signaling pathways that converge on Nix expression and function. Dorsomorphin, a AMP-activated protein kinase (AMPK) inhibitor, indirectly influences Nix by targeting AMPK-dependent pathways. By inhibiting AMPK, Dorsomorphin disrupts downstream events, including the regulation of Nix. FK866, a NAMPT inhibitor, indirectly influences Nix by targeting NAD+ metabolism, providing an indirect mechanism for inhibiting Nix-mediated processes by disrupting the intricate network of signaling pathways that converge on Nix expression and function.
3-Methyladenine, a class III phosphoinositide 3-kinase (PI3K) inhibitor, indirectly influences Nix by targeting autophagy. By inhibiting PI3K, 3-Methyladenine disrupts the autophagic process, leading to altered Nix degradation. GSK872, a TBK1 inhibitor, indirectly influences Nix by targeting the TBK1 pathway, shedding light on the regulatory mechanisms governing Nix expression. Gamitrinib, a mitochondrial Hsp90 inhibitor, indirectly influences Nix by targeting mitochondrial chaperones. These Nix inhibitors offer a comprehensive toolkit for researchers aiming to dissect the regulatory networks governing Nix expression and function. The diverse mechanisms of action of these chemicals provide unique insights into the intricate signaling pathways that converge on Nix, contributing to our understanding of the molecular events regulated by Nix in various cellular contexts.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $168.00 | ||
Spautin-1, an autophagy inhibitor, indirectly influences Nix by targeting the autophagic pathway. By inhibiting USP10 and USP13, Spautin-1 disrupts the deubiquitination of Beclin-1, leading to enhanced autophagy and subsequent degradation of Nix. The modulation of autophagy by Spautin-1 provides an indirect mechanism for inhibiting Nix-mediated processes by disrupting the intricate network of signaling pathways that converge on Nix expression and function. | ||||||
Mdivi-1 | 338967-87-6 | sc-215291 sc-215291B sc-215291A sc-215291C | 5 mg 10 mg 25 mg 50 mg | $67.00 $126.00 $251.00 $465.00 | 13 | |
Mdivi-1, a mitochondrial division inhibitor, directly influences Nix by targeting mitochondrial fission. By inhibiting Drp1, Mdivi-1 disrupts the division of mitochondria, preventing the translocation of Nix to the mitochondria. The direct inhibition of Drp1 by Mdivi-1 provides a specific tool for studying Nix-related cellular processes, offering insights into the regulatory mechanisms governing Nix localization and mitochondrial dynamics. | ||||||
Carbonyl Cyanide m-Chlorophenylhydrazone | 555-60-2 | sc-202984A sc-202984 sc-202984B | 100 mg 250 mg 500 mg | $77.00 $153.00 $240.00 | 8 | |
CCCP (carbonyl cyanide m-chlorophenyl hydrazine), a mitochondrial uncoupler, indirectly influences Nix by disrupting mitochondrial membrane potential. CCCP uncouples oxidative phosphorylation, leading to mitochondrial depolarization and the inhibition of Nix translocation to mitochondria. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
BML-275 (Dorsomorphin), an AMP-activated protein kinase (AMPK) inhibitor, indirectly influences Nix by targeting AMPK-dependent pathways. By inhibiting AMPK, Dorsomorphin disrupts downstream events, including the regulation of Nix. | ||||||
FK-866 | 658084-64-1 | sc-205325 sc-205325A | 5 mg 10 mg | $143.00 $250.00 | 12 | |
FK866, a NAMPT inhibitor, indirectly influences Nix by targeting NAD+ metabolism. By inhibiting NAMPT, FK866 disrupts NAD+ synthesis, leading to altered SIRT1 activity and subsequent modulation of Nix expression. The modulation of NAD+ metabolism by FK866 provides an indirect mechanism for inhibiting Nix-mediated processes by disrupting the intricate network of signaling pathways that converge on Nix expression and function. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
3-Methyladenine, a class III phosphoinositide 3-kinase (PI3K) inhibitor, indirectly influences Nix by targeting autophagy. By inhibiting PI3K, 3-Methyladenine disrupts the autophagic process, leading to altered Nix degradation. The modulation of autophagy by 3-Methyladenine provides an indirect mechanism for inhibiting Nix-mediated processes by disrupting the intricate network of signaling pathways that converge on Nix expression and function. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $75.00 | 256 | |
Z-VAD-FMK, a pan-caspase inhibitor, indirectly influences Nix by targeting apoptosis. By inhibiting caspases, Z-VAD-FMK disrupts the apoptotic process, leading to altered Nix activation and translocation. The modulation of apoptosis by Z-VAD-FMK provides an indirect mechanism for inhibiting Nix-mediated processes by disrupting the intricate network of signaling pathways that converge on Nix expression and function. | ||||||
Necrostatin-1 | 4311-88-0 | sc-200142 sc-200142A | 20 mg 100 mg | $94.00 $343.00 | 97 | |
Necrostatin-1, a RIP1 kinase inhibitor, indirectly influences Nix by targeting necroptosis. By inhibiting RIP1 kinase, Necrostatin-1 disrupts the necroptotic process, leading to altered Nix activation and translocation. The modulation of necroptosis by Necrostatin-1 provides an indirect mechanism for inhibiting Nix-mediated processes by disrupting the intricate network of signaling pathways that converge on Nix expression and function. | ||||||